Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-28

FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Exforge (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation. This action updates the appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exforge (valsartan; amlodipine)

Snippet

SUPPL AP for EXFORGE (AMLODIPINE BESYLATE AND VALSARTAN)